<?xml version="1.0" encoding="UTF-8"?>
<p id="p0090">Another explanation is protection against SARS-CoV-2 induced by vaccines used against other pathogens. It seems that bacillus Calmette–Guérin (BCG) vaccination could protect from COVID-19. A strong association was observed between BCG vaccination deployment and COVID-19 mortality [
 <xref rid="bib109" ref-type="bibr">109</xref>,
 <xref rid="bib110" ref-type="bibr">110</xref>]. Countries where BCG vaccination is given at birth showed lower numbers of COVID-19 cases and deaths [
 <xref rid="bib111" ref-type="bibr">111</xref>]. In fact, a SARS-CoV-2 envelope protein is closely related to a 
 <italic>Mycobacterium bovis</italic> protein and BCG vaccine could induce a specific immunity against SARS-CoV-2 by targeting its essential viral envelope protein [
 <xref rid="bib112" ref-type="bibr">112</xref>]. Moreover, the fatality rate due to COVID-19 was lower in Asian countries where Japanese encephalitis immunization is recommended compared with those were the population is not vaccinated [
 <xref rid="bib113" ref-type="bibr">113</xref>].
</p>
